SCHEDULE 13D/A: Access Industries Affiliates Maintain 10.8% Stake in Disc Medicine, Inc. Through Latest SEC Filing
Beneficial Ownership Update
Access Industries and its affiliated entities have filed an Amendment No. 5 to their Schedule 13D, confirming their continued beneficial ownership of 10.8% of Disc Medicine, Inc.'s common stock.
Summary
- AI DMI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik (collectively, the "Reporting Persons") have filed Amendment No. 5 to their Schedule 13D regarding their holdings in Disc Medicine, Inc.
- The Reporting Persons collectively beneficially own 3,762,507 shares of Disc Medicine, Inc. Common Stock.
- This ownership stake represents 10.8% of the Issuer's total outstanding Common Stock.
- The total beneficial ownership includes 3,558,426 shares of Common Stock and 204,081 pre-funded warrants to purchase shares of Common Stock.
- The percentage of ownership is calculated based on 34,773,123 shares of Common Stock, which includes 34,569,042 shares outstanding as of February 21, 2025 (as reported in the Issuer's 10-K) and the 204,081 shares underlying the pre-funded warrants.
- Len Blavatnik controls Access Industries Management, LLC and holds a majority of the outstanding voting interests in Access Industries Holdings LLC, which in turn controls AI DMI LLC, establishing the beneficial ownership chain.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, providing neutral information without indicating positive or negative sentiment regarding the company's performance or outlook. It simply updates the public record on a significant shareholder's stake.
Future Outlook
This filing is an update to beneficial ownership and does not contain forward-looking statements or guidance regarding the Issuer's future operations or financial performance.
Industry Context
This filing is a routine disclosure of a significant shareholder's updated ownership stake in a publicly traded biotechnology company. It does not provide specific insights into broader industry trends or competitive landscape beyond the ownership structure itself.
Related Party Transactions
- The beneficial ownership is held by AI DMI LLC, which is indirectly controlled by Access Industries Holdings LLC and Access Industries Management, LLC, both ultimately controlled by Len Blavatnik. This structure represents related party control over the reported shares.
Stakeholder Impact
- Shareholders: Provides transparency regarding the continued significant ownership stake of Access Industries, a major investor, which can offer a degree of stability or confidence in the company's long-term prospects from a governance perspective.
Key Dates
| Date | Description |
|---|---|
| 2023-01-09 | Original Schedule 13D filed by the Reporting Persons. |
| 2023-02-17 | Amendment No. 1 to Schedule 13D filed. |
| 2023-06-20 | Amendment No. 2 to Schedule 13D filed. |
| 2023-11-13 | Amendment No. 3 to Schedule 13D filed. |
| 2024-06-20 | Amendment No. 4 to Schedule 13D filed. |
| 2025-02-21 | Date as of which 34,569,042 shares of Common Stock were reported outstanding in the Issuer's Annual Report on Form 10-K. |
| 2025-02-27 | Date of event which required the filing of this statement; also the filing date of the Issuer's Annual Report on Form 10-K. |
| 2025-03-03 | Date of filing of Amendment No. 5 to Schedule 13D. |
Keywords
Disc Medicine, Access Industries, Schedule 13D, Beneficial Ownership, Common Stock, Pre-Funded Warrants, SEC Filing, Investment, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.